Citius Oncology, Inc.: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 28, 2022 and accepted by EDGAR at Nov 28, 2022, 16:55 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Basic EPS | 3 months2022-07-01 to 2022-09-30 | $0.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-01 to 2022-09-30 | $0.00 | us-gaap:EarningsPerShareBasic |
| Total assets | At period end2022-09-30 | $256.7k | us-gaap:Assets |
| Current liabilities | At period end2022-09-30 | $266.9k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2022-09-30 | −$10.1k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-22-033847. Last ingested by Listed: Nov 14, 2026, 21:33 ET. Listed shows no prices and gives no investment advice.